Delphine Rolland

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

Yaël P. Mossé, Megan S. Lim, Stephan D. Voss et al. · The Lancet Oncology · 2013 · 701 citations · Full text

Medicine, Oncology, Pediatrics +11

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study

Yaël P. Mossé, Stephan D. Voss, Megan S. Lim et al. · Journal of Clinical Oncology · 2017 · 403 citations · Full text

Medicine, Oncology, Pharmacology +15

Activating <i>FGFR2–RAS–BRAF</i> Mutations in Ameloblastoma

Noah A. Brown, Delphine Rolland, Jonathan B. McHugh et al. · Clinical Cancer Research · 2014 · 298 citations · Full text

Medicine, Cancer Biology, Oncology +17

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

Mark J. Kiel, Thirunavukkarasu Velusamy, Delphine Rolland et al. · Blood · 2014 · 255 citations · Full text

Life Sciences, Genetics, Oncology +14

Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome

Mark J. Kiel, Anagh A. Sahasrabuddhe, Delphine Rolland et al. · Nature Communications · 2015 · 202 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17